Sanford Health is now administering COVID-19, influenza and RSV vaccine for eligible patients at its clinic locations across its footprint in North Dakota, South Dakota, Northwest Iowa, Minnesota and ...

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.

Over 1,800 people in Montana had to be hospitalized with either influenza or COVID-19 during the last respiratory illness ...

Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.

The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...

They are respiratory infections that cause similar symptoms such as coughing, fever and fatigue. These illnesses can range ...

Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people ...

Pfizer's RSV vaccine Abrysvo receives FDA approval for adults 18-59 at high risk, with extended use for pregnant individuals ...

While it’s a win for Pfizer over GSK and its RSV vaccine Arexvy, which is approved for those 50 and older, it’s difficult to ...

They are respiratory infections that cause similar symptoms such as coughing, fever and fatigue. These illnesses can range ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...